Emory University and Eurofins Scientific Sign Joint Venture

Published on 06/29/15
Emory University's School of Medicine and its EGL Genetics (EGL) and Eurofins Scientific (Eurofins), a global leader in bio-analytical testing and genomic services, announced that they have entered into a joint venture that calls for Eurofins to acquire a controlling interest in EGL. Pending regulatory approvals, EGL will be re-named EGL Genetic Diagnostics, LLC. To read the complete story, please click here.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.